trial ( 17 ) showed an increasing trend in the serum inflammatory biomarkers such as soluble TNF receptor 1, neutrophil gelatinase-associated lipocalin, and vascular cell adhesion molecule 1 during the 18-month follow-up period, with no difference between groups.
← all excerpts
Efficacy of stem cell therapy for diabetic kidney disease: a systematic review and meta-analysis.
1
—
—